Erratum to Serum IL33 a new marker predicting response to rituximab in rheumatoid arthritis Bioportfolio, 23 Jan 2017 Related Biotechnology, Pharmaceutical and Healthcare News Original Article: Erratum to: Serum IL-33, a new marker predicting…